Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole for the treatment of spasticity in chronic traumatic spinal cord injury
2016-000901-35Phase 2Active
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in spinal cord injury (SCI) comparing Riluzole with Placebo (2 arms). Primary endpoint: Improvement in spasticity at Week 2. Started Oct 2017; status: active.
02
Drugs
riluzole
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on 2016-000901-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000901-35.